Discover 1,846 paid clinical trials in Tennessee. Search by city or condition to find a research study near you that matches your needs across various therapeutic areas.
Whether you're a healthy volunteer interested in paid studies or someone looking for trials focused on specific conditions, Tennessee offers a wide variety of clinical research options. Leading facilities in Nashville, Memphis, and Knoxville are currently seeking participants, providing opportunities for individuals to access innovative treatments and specialized healthcare.
Filter
1
Filter results
Results: 1,846
Clinical Study of Ivonescimab for First-line Treatment of Metastatic NSCLC Patients With High PD-L1
for
Non-Small Cell Lung Cancer
Location: Milford MA, Weymouth MA, Brighton MA, Boston MA,
Sponsor: Summit Therapeutics
Sex: All
Age: 18+
Code: NCT06767514
Phase3, Recruiting
GEMINI-NSCLC: NSCLC Biomarker Study
for
Non-Small Cell Lung Cancer
Location: Norwich CT, White Plains NY, New York NY, Belleville NJ,
Sponsor: Tempus AI
Sex: All
Age: 18+
Code: NCT05236114
Recruiting
Immunonutrition in Ulcerative Colitis
for
Ulcerative Colitis
Location: Memphis TN
Sponsor: Baptist Memorial Health Care Corporation
Sex: All
Age: 18+
Code: NCT03594708
Recruiting
Neoadjuvant Neratinib in Stage I-III HER2-Mutated Lobular Breast Cancers
for
Anatomic Stage I Breast Cancer, Anatomic Stage II Breast Cancer,
Location: Nashville TN, Dallas TX
Sponsor: Vanderbilt-Ingram Cancer Center
Sex: All
Age: 18+
Code: NCT05919108
Phase2, Recruiting
Study to Assess the Impact of the Urine Test Cxbladder Triage Plus on the Number of Cystoscopies Performed on Patients With Invisible Blood in Their Urine.
for
Hematuria - Cause Not Known
Location: New York NY, Poughkeepsie NY, Albany NY,
Sponsor: Pacific Edge Limited
Sex: All
Age: 18 - 70+
Code: NCT06394869
Recruiting
Interested in new trials?
Get alerts for new trials in your area by subscribing now
A Multi-Institution Study of TGFβ Imprinted, Ex Vivo Expanded Universal Donor NK Cell Infusions as Adoptive Immunotherapy in Combination With Gemcitabine and Docetaxel in Patients With Relapsed or Refractory Pediatric Bone and Soft Tissue
Location: Virginia Beach VA, Charlottesville VA, Chapel Hill NC,
Sponsor: Arthrex, Inc.
Sex: All
Age: 18 - 70+
Code: NCT03511586
Recruiting
Studying Health Outcomes After Treatment in Patients With Retinoblastoma
for
Retinoblastoma, Cancer Survivor, Biological Sibling,
Location: Philadelphia PA, Toronto, Cincinnati OH, Nashville TN,
Sponsor: Vanderbilt-Ingram Cancer Center
Sex: All
Age: 0+
Code: NCT03932786
Recruiting
Study of MTB-9655, an Inhibitor of ACSS2, in Patients With Advanced Solid Tumors
for
Advanced Solid Tumor
Location: Nashville TN
Sponsor: MetaboMed Inc
Sex: All
Age: 18+
Code: NCT04990739
Phase1, Recruiting
CAR-T Long Term Follow Up (LTFU) Study
for
Long Term Safety of Patients Receiving CAR-T in an Eligible Clinical Trial or Managed Access Program,
Location: Boston MA, Montreal, Philadelphia PA, Durham NC,
Sponsor: Novartis Pharmaceuticals
Sex: All
Age: 0 - 70+
Code: NCT02445222
Phase3, Recruiting
Testing the Addition of Abemaciclib to Olaparib for Women With Recurrent Ovarian Cancer
for
Recurrent Ovarian High Grade Serous Adenocarcinoma,
Location: Philadelphia PA, Charlottesville VA, Winston-Salem NC,
Sponsor: National Cancer Institute (NCI)
Sex: Female
Age: 18+
Code: NCT04633239
Phase1, Recruiting
Study of AU-007, A Monoclonal Antibody That Binds to IL-2 and Inhibits IL-2Rα Binding, in Patients With Unresectable Locally Advanced or Metastatic Cancer